InvestorsHub Logo
Followers 13
Posts 638
Boards Moderated 0
Alias Born 09/10/2009

Re: None

Thursday, 06/05/2014 7:24:38 PM

Thursday, June 05, 2014 7:24:38 PM

Post# of 24848
Alleyba says........................

..........that in his opinion CEO made the correct and bold move by restructuring the crux of this company by moving into the compounding drug niche. It would not surprise me if CEO were looking for other companies similar to Main Avenue to acquire..........and let us not forget our other revenue streams. I would agree with my fellow longs that we can easily be between $1.50-$2 given the numbers company is doing on compounding alone and then factor in the other revenue streams. This is a long term hold and an excellent buy at this price